Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan

K Maeda1, T Shimbo, T Fukui

  • 1Department of General Medicine and Clinical Epidemiology, Kyoto University Graduate School of Medicine, Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. maeken@kuhp.kyoto-u.ac.jp

Insights

Community screening for atrial fibrillation (AF) using ECG or pulse palpation is cost-effective in Japan. Both methods prevent ischaemic stroke and are favorable within standard cost-effectiveness criteria.

Area of Science:

  • Health Economics
  • Cardiology
  • Preventive Medicine

Background:

  • Atrial fibrillation (AF) is a significant risk factor for ischaemic stroke.
  • Early detection and treatment of AF can mitigate stroke risk.
  • Cost-effectiveness of screening programs is crucial for healthcare resource allocation.

Purpose of the Study:

  • To evaluate the cost-effectiveness of community-based screening for chronic atrial fibrillation (AF) in Japan.
  • To compare annual ECG screening and annual pulse palpation screening against no screening.
  • To assess the economic impact of AF screening on preventing ischaemic stroke.

Main Methods:

  • A Markov process computer model simulated a hypothetical Japanese population aged 65-85.
  • Compared annual ECG screening, annual pulse palpation screening, and no screening.
  • Modeled outcomes including quality-adjusted life-years (QALYs), costs, anticoagulation therapy, stroke incidence, and hemorrhage risks.

Main Results:

  • Both ECG and pulse palpation screening were more effective and costlier than no screening.
  • Incremental cost-effectiveness ratios were approximately $8,000/QALY (males) and $10,000/QALY (females).
  • Screening programs showed similar effectiveness and costs; results were sensitive to stroke incidence and anticoagulant prescription rates.

Conclusions:

  • Annual ECG and pulse palpation screening for AF are cost-effective strategies in Japan.
  • These screening methods are favorable for preventing ischaemic stroke associated with AF.
  • Both screening approaches align with conventional cost-effectiveness criteria.
Abstract